PCN51 PROJECTED LONG-TERM ECONOMIC OUTCOMES ASSOCIATED WITH BEVACIZUMAB TREATMENT IN PATIENTS WITH ADJUVANT TRIPLENEGATIVE BREAST CANCER TO INFORM EARLY DECISION MAKING
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73288-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)73288-5/fulltext
Section Title :
Section Order :
710
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73288-5&doi=10.1016/S1098-3015(10)73288-5